Multimodal Advances Transforming Gastric Cancer Management
Recent updates in multimodal treatment are reshaping gastric cancer care, impacting surgical strategies and patient outcomes.
Newsletter
Best Papers in General Surgery
The five that matter, every day.
Recent updates in multimodal treatment are reshaping gastric cancer care, impacting surgical strategies and patient outcomes.
Laparoscopic gastrectomy plus hyperthermic intraperitoneal chemotherapy (HIPEC) improves outcomes for gastric cancer patients with positive peritoneal lavage cytology.
Fluorescence imaging using indocyanine green significantly improves surgical outcomes in colorectal procedures.
A refined robotic surgical training curriculum enhances skill acquisition while significantly lowering training time.
Understanding the risk factors for hepatocellular carcinoma (HCC) rupture can improve surgical outcomes.
Consider one-stage approaches as a first option for eligible patients, with two-stage surgery reserved for more complex cases.
Laparoscopic liver resection (LLR) for malignancies in segment 7 is a viable option, with potential short-term benefits.
A newly developed nomogram predicts the risk of parastomal hernia in patients undergoing permanent colostomy for rectal cancer, crucial for improving patient outcomes.
A dual-energy CT radiomics model can better predict neoadjuvant chemotherapy response in locally advanced gastric cancer, impacting surgical decision-making.
A novel Neutrophil-C-Reactive Protein Index (NCI) can enhance risk stratification for severe acute pancreatitis and in-hospital mortality, crucial in resource-limited settings.